Recombinant antibodies: Engineering and production in yeast and bacterial hosts

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Biotechnology Journal

• Publication date

  2011-01-01

• Fields of study

  Biology, Medicine, Engineering

• Identifiers
  DOI 10.1002/biot.201000381PMID 21170983
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enhancing the secretory yields of leech carboxypeptidase inhibitor in Escherichia coli: influence of trigger factor and signal recognition particle.

  2010cited by this paper
• A combined method for producing homogeneous glycoproteins with eukaryotic N-glycosylation

  2010cited by this paper
• Reduced elimination of IgG antibodies by engineering the variable region.

  2010cited by this paper
• Research and development of next generation of antibody-based therapeutics

  2010influential reference
• Efficient expression and purification of human aglycosylated Fcγ receptors in Escherichia coli

  2010cited by this paper
• Native-sized recombinant spider silk protein produced in metabolically engineered Escherichia coli results in a strong fiber

  2010cited by this paper
• Optimized Expression of Full-Length IgG1 Antibody in a Common E. coli Strain

  2010cited by this paper
• Antibody expression kinetics in glycoengineered Pichia pastoris

  2010cited by this paper
• Functional expression of single-chain Fv antibody in the cytoplasm of Escherichia coli by thioredoxin fusion and co-expression of molecular chaperones.

  2010cited by this paper
• Introducing antigen-binding sites in structural loops of immunoglobulin constant domains: Fc fragments with engineered HER2/neu-binding sites and antibody properties.

  2010cited by this paper
• Enhanced antibody half-life improves in vivo activity

  2010cited by this paper
• The response to unfolded protein is involved in osmotolerance of Pichia pastoris

  2010cited by this paper
• Directed evolution of a secretory leader for the improved expression of heterologous proteins and full‐length antibodies in Saccharomyces cerevisiae

  2009cited by this paper
• Engineering antibody fragments to fold in the absence of disulfide bonds

  2009cited by this paper
• Technological progresses in monoclonal antibody production systems

  2009cited by this paper
• Expression of active human sialyltransferase ST6GalNAcI in Escherichia coli

  2009cited by this paper
• Aglycosylated IgG variants expressed in bacteria that selectively bind FcγRI potentiate tumor cell killing by monocyte-dendritic cells

  2009cited by this paper
• Efficient production of single-chain Fv antibody possessing rare codon linkers in fed-batch fermentation.

  2009cited by this paper
• Production of monoclonal antibodies by glycoengineered Pichia pastoris.

  2009cited by this paper
• Development of cell‐free protein synthesis platforms for disulfide bonded proteins

  2008cited by this paper
• Effect of Increased Expression of Protein Disulfide Isomerase and Heavy Chain Binding Protein on Antibody Secretion in a Recombinant CHO Cell Line

  2008cited by this paper
• Engineering therapeutic monoclonal antibodies

  2008cited by this paper
• Aglycosylated immunoglobulin G1 variants productively engage activating Fc receptors

  2008cited by this paper
• APEx 2-hybrid, a quantitative protein–protein interaction assay for antibody discovery and engineering

  2007cited by this paper
• Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcgamma receptors.

  2007cited by this paper
• Process economics of industrial monoclonal antibody manufacture.

  2007cited by this paper
• Production of single-chain variable fragment antibody (scFv) in fed-batch and continuous culture of Pichia pastoris by two different methanol feeding methods.

  2007cited by this paper
• Cooverexpression of chaperones for enhanced secretion of a single-chain antibody fragment in Pichia pastoris

  2007cited by this paper
• Antibody production with yeasts and filamentous fungi: on the road to large scale?

  2007cited by this paper
• A scFv antibody mutant isolated in a genetic screen for improved export via the twin arginine transporter pathway exhibits faster folding.

  2007influential reference
• Isolation of engineered, full-length antibodies from libraries expressed in Escherichia coli

  2007cited by this paper
• Engineering of Pichia pastoris for improved production of antibody fragments

  2006influential reference
• Signal sequences directing cotranslational translocation expand the range of proteins amenable to phage display

  2006cited by this paper
• Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune disease.

  2006cited by this paper
• Optimization of humanized IgGs in glycoengineered Pichia pastoris

  2006cited by this paper
• Oxygen-limited control of methanol uptake for improved production of a single-chain antibody fragment with recombinant Pichia pastoris

  2006cited by this paper
• Definition of the bacterial N‐glycosylation site consensus sequence

  2006cited by this paper
• Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels

  2005cited by this paper
• Improvements in the cell-free production of functional antibodies using cell extract from protease-deficient Escherichia coli mutant.

  2005cited by this paper
• Proteomic Profiling of Recombinant Escherichia coli in High-Cell-Density Fermentations for Improved Production of an Antibody Fragment Biopharmaceutical

  2005cited by this paper
• Production of recombinant humanized anti-HBsAg Fab fragment from Pichia pastoris by fermentation.

  2005cited by this paper
• High‐level accumulation of a recombinant antibody fragment in the periplasm of Escherichia coli requires a triple‐mutant (degP prc spr) host strain

  2004cited by this paper
• Production of recombinant protein therapeutics in cultivated mammalian cells

  2004cited by this paper
• Broad-Host-Range Plasmid pJB658 Can Be Used for Industrial-Level Production of a Secreted Host-Toxic Single-Chain Antibody Fragment in Escherichia coli

  2004cited by this paper
• Antibody pharmacokinetics and pharmacodynamics.

  2004cited by this paper
• An optimized fermentation process for high-level production of a single-chain Fv antibody fragment in Pichia pastoris.

  2004cited by this paper
• Chaperone-assisted folding of a single-chain antibody in a reconstituted translation system.

  2004cited by this paper
• Production of a single-chain variable fraction capable of inhibiting the Streptococcus mutans glucosyltransferase in Bacillus brevis: construction of a chimeric shuttle plasmid secreting its gene product.

  2003cited by this paper
• Isolation and expression of recombinant antibody fragments to the biological warfare pathogen Brucella melitensis.

  2003cited by this paper
• Effects of Inactivation and Constitutive Expression of the Unfolded- Protein Response Pathway on Protein Production in the Yeast Saccharomyces cerevisiae

  2003cited by this paper
• Production of a functional catalytic antibody ScFv-NusA fusion protein in bacterial cytoplasm.

  2003cited by this paper
• Expression of full-length immunoglobulins in Escherichia coli: rapid and efficient production of aglycosylated antibodies.

  2002influential reference
• Functional Production and Characterization of a Fibrin-Specific Single-Chain Antibody Fragment from Bacillus subtilis: Effects of Molecular Chaperones and a Wall-Bound Protease on Antibody Fragment Production

  2002cited by this paper
• Lack of Fucose on Human IgG1 N-Linked Oligosaccharide Improves Binding to Human FcγRIII and Antibody-dependent Cellular Toxicity*

  2002cited by this paper
• Factors affecting the production of a single-chain antibody fragment by Aspergillus awamori in a stirred tank reactor.

  2001cited by this paper
• Production of correctly folded Fab antibody fragment in the cytoplasm of Escherichia coli trxB gor mutants via the coexpression of molecular chaperones.

  2001cited by this paper
• High Resolution Mapping of the Binding Site on Human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and Design of IgG1 Variants with Improved Binding to the FcγR*

  2001cited by this paper
• Mapping of the C1q Binding Site on Rituxan, a Chimeric Antibody with a Human IgG1 Fc

  2000influential reference
• The Periplasmic Escherichia coli Peptidylprolyl cis,trans-Isomerase FkpA

  2000cited by this paper
• Specific Secretion of Active Single-Chain Fv Antibodies into the Supernatants of Escherichia coliCultures by Use of the Hemolysin System

  2000cited by this paper
• The Periplasmic Escherichia coli Peptidylprolyl cis,trans-Isomerase FkpA

  2000cited by this paper
• Identification of Framework Residues in a Secreted Recombinant Antibody Fragment That Control Production Level and Localization inEscherichia coli *

  1997cited by this paper
• High volumetric yields of functional dimeric miniantibodies in Escherichia coli, using an optimized expression vector and high-cell-density fermentation under non-limited growth conditions

  1996cited by this paper
• High Level Escherichia coli Expression and Production of a Bivalent Humanized Antibody Fragment

  1992cited by this paper
• Microbial Cell Factories Production of Recombinant Antibody Fragments in Bacillus Megaterium

  year unknowncited by this paper

• Engineering Saccharomyces cerevisiae for medical applications

  2025cites this paper
• A Kaleidoscope of Hosts: Expression Systems of Recombinant Antibody Reagents for Immunological Assays.

  2025cites this paper
• Protein Expression Platforms and the Challenges of Viral Antigen Production

  2024cites this paper
• Recombinant monoclonal antibody production in yeasts: Challenges and considerations.

  2024cites this paper
• Development of Recombinant Antibody and Application of Colloidal Gold Immunochromatography Assay for Rapid Detection of Zearalenone

  2024cites this paper
• From strain engineering to process development: monoclonal antibody production with an unnatural amino acid in Pichia pastoris

  2022cites this paper
• Expression in Pichia pastoris of human antibody fragments that neutralize venoms of Mexican scorpions.

  2022cites this paper
• A history of adventitious agent contamination and the current methods to detect and remove them from pharmaceutical products.

  2022cites this paper
• Virus Detection: A Review of the Current and Emerging Molecular and Immunological Methods

  2021cites this paper
• Production of a Recombinant Single-Domain Antibody for Gluten Detection in Foods Using the Pichia pastoris Expression System

  2020cites this paper
• Extracellular production of functional single‐chain variable fragment against aflatoxin B1 using Escherichia coli

  2019cites this paper
• The Overt and Hidden Use of Animal-Derived Products in Alternative Methods for Skin Sensitisation: A Systematic Review

  2019cites this paper
• Quality and cost assessment of a recombinant antibody fragment produced from mammalian, yeast and prokaryotic host cells: A case study prior to pharmaceutical development.

  2018cites this paper
• Scale up of biopharmaceuticals production

  2018cites this paper
• Understanding cell lysis in fermentation and its impact on primary recovery using viscosity monitoring

  2018cites this paper
• Therapeutic treatment with scFv-PLGA nanoparticles decreases pulmonary fungal load in a murine model of paracoccidioidomycosis.

  2017cites this paper
• Bicistronic expression strategy for high‐level expression of recombinant proteins in Corynebacterium glutamicum

  2017cites this paper
• Detection and purification of backbone-cyclized proteins using a bacterially expressed anti-myc-tag single chain antibody.

  2017cites this paper
• Optimizing antibody expression: The nuts and bolts.

  2017cites this paper
• Importance of Hypervariable Region 2 for Stability and Affinity of a Shark Single-Domain Antibody Specific for Ebola Virus Nucleoprotein

  2016cites this paper
• Development of high-affinity single chain Fv against foot-and-mouth disease virus.

  2016cites this paper
• The History of Therapeutic Monoclonal Antibodies

  2016cites this paper
• Discovery and characterization of hydroxylysine in recombinant monoclonal antibodies

  2016cites this paper
• Production and Purification of Recombinant Proteins from Escherichia coli

  2016cites this paper
• Targeting bottlenecks in the secretory pathway of yeast

  2016influential citation
• Nanoplasmonic biosensors for clinical diagnosis at the point of care

  2015cites this paper
• scFv from Antibody That Mimics gp43 Modulates the Cellular and Humoral Immune Responses during Experimental Paracoccidioidomycosis

  2015cites this paper
• Challenges to production of antibodies in bacteria and yeast.

  2015cites this paper
• Pichia pastoris: a workhorse for recombinant protein production

  2014cites this paper
• Bispecific antibody platforms for cancer immunotherapy.

  2014cites this paper
• Over-expression of secreted proteins from mammalian cell lines

  2014cites this paper
• Engineering an aglycosylated Fc variant for enhanced FcγRI engagement and pH-dependent human FcRn binding

  2014cites this paper
• Rearranging the domain order of a diabody-based IgG-like bispecific antibody enhances its antitumor activity and improves its degradation resistance and pharmacokinetics

  2014cites this paper
• Enhanced production of human full-length immunoglobulin G1 in the periplasm of Escherichia coli

  2014cites this paper
• High-level production of Fc-fused kringle domain in Pichia pastoris

  2014cites this paper
• Overproduction of a C5a receptor antagonist (C5aRA) in Escherichia coli.

  2013cites this paper
• Pichia pastoris: a recombinant microfactory for antibodies and human membrane proteins.

  2013cites this paper
• Methodologies for the isolation of alternative binders with improved clinical potentiality over conventional antibodies

  2013influential citation
• Production of recombinant immunotherapeutics for anticancer treatment

  2013cites this paper
• Expression of Recombinant Antibodies

  2013cites this paper
• Methodologies for the isolation of alternative binders with improved clinical potentiality over conventional antibodies.

  2013cites this paper
• High-level secretory production of recombinant single-chain variable fragment (scFv) in Corynebacterium glutamicum

  2013influential citation
• Generation and Comparative Characterization of Glycosylated and Aglycosylated Human IgG1 Antibodies

  2013cites this paper
• Construction of an scFv library by enzymatic assembly of V(L) and V(H) genes.

  2013cites this paper
• Production and characterization of peptide antibodies.

  2012cites this paper
• 280GSM Heavy Weight Factory Direct Wholesale Price of 8.3oz Plain Dyed Woven Technics Poly Cotton 65/35 Canvas Fabric for Workwear/Garment/Safety Police Uniform

  2012cites this paper
• Microbial Expression Systems and Manufacturing from a Market and Economic Perspective

  2012cites this paper
• Molecular engineering of antibodies for therapeutic and diagnostic purposes

  2012cites this paper
• A combined strategy improves the solubility of aggregation-prone single-chain variable fragment antibodies.

  2012cites this paper
• Yeasts in Biotechnology

  2012cites this paper
• The effect of antifoams upon recombinant protein production in yeast

  2012cites this paper
• Editorial: BTJ – looking back to look ahead

  2012cites this paper
• Lactobacillus plantarum and Lactobacillus buchneri as Expression Systems: Evaluation of Different Origins of Replication for the Design of Suitable Shuttle Vectors

  2012cites this paper
• Using antibodies to target cancer therapeutics

  2012cites this paper
• Yohimbine Hydrochloride/Yohimbine HCl CAS 65-19-0

  2012cites this paper
• Cold-Rolled Steel Medium Duty Warehouse Sheet Metal Storage Rack

  2012cites this paper
• Black Glass Flower Tea Pot with Stainless Steel Infuser GB1164-1

  2012cites this paper
• Comfortable Living Room Leisure Bedroom Sofa Chair Iron Metal Frame

  2012cites this paper
• Mechanical Shaft Forging and Machining

  2012cites this paper
• Anti-Fog on/off Sensor Switch Bathroom LED Mirror Illuminated Mirror with PVC Cover

  2012cites this paper
• 1m3 Hydraulic Orange Peels Steel Scrap Grab Bucket for Komat′su Excavator

  2012cites this paper
• PE Heat Shrink Film Plastic Packing Film for Wooden/ Coth and Other Cans

  2012cites this paper
• 9-32V 85mm GPS Speedometer Tachometer Oil Pressure Water Temp Voltmeter Fuel Level Odo Meter with Backlight for Auto Boat Gauges

  2012cites this paper
• 20FT/40 FT Folding Prefab Container Home/Flat Pack House as School/Modular School/Prefab School

  2012cites this paper
• Genome-scale metabolic model of the fission yeast Schizosaccharomyces pombe and the reconciliation of in silico/in vivo mutant growth

  2012cites this paper
• Beyond de-foaming: the effects of antifoams on bioprocess productivity

  2012cites this paper
• High-level production of a kringle domain variant by high-cell-density cultivation of Escherichia coli

  2011cites this paper
• Production in yeast of pseudotype virus-like particles harboring functionally active antibody fragments neutralizing the cytolytic activity of vaginolysin

  2011cites this paper
• Enhanced production of human FcγRIIa receptor by high cell density cultivation of Escherichia coli.

  2011cites this paper
• Recombinant Protein Production by In Vivo Polymer Inclusion Display

  2011cites this paper